Intramuscular versus intravenous therapy for status epilepticus

<blockquote class=’posterous_long_quote’><div class=”abstr”><h4>CONCLUSIONS: </h4><p>For

subjects in status epilepticus, intramuscular midazolam is at least as safe and effective as intravenous lorazepam for prehospital seizure cessation. (Funded by the National Institute of Neurological Disorders and Stroke and others; ClinicalTrials.gov number, ClinicalTrials.gov NCT00809146.).</p></div><div class=”err”><h3>Comment in</h3><ul><li>N Engl J Med. 2012 Feb 16;366(7):659-60.</li></ul></div></blockquote>

For patients is status epilepticus, it is safe and effective to use IM midazolam rather than IV benzos.